Cardiac magnetic resonance in non-ischemic cardiomyopathies

    Authors

    Abstract

    Cardiomyopathies are diseases of cardiomyocytes or different heart structures which are manifested through changes in morphology or function of the heart. Due to relatively non-negligible prevalence and clinical course, cardiomyopathies are significant public health burden in terms of increased utilization of medical services, impairing quality of life, as well as mortality. In the last decades, cardiac magnetic resonance (CMR) became important clinical tool in management of patients with non-ischemic cardiomyopathy (NICMP). CMR offers virtue of non-invasive 3D imaging of cardiac structures and function, and owing the advances in technology, there is a relatively constant pace of improvements in spatial, temporal resolutions, as well as tissue characterization. For these reasons use of CMR increases in every day clinical practice and growing number of centers is available. CMR brings diagnostic and prognostic advances in managed care of patients with cardiomyopathies, with ability to influence course of treatment and the most important increase survival of patients. Typical complications within the course of NICMP like development of heart failure, malignant arrhythmia and cardiac death could be verified, in part foreseen, and to different degree ameliorated by use of CMR. (1, 2) This lecture will present the most important issues around utilization of CMR in clinical management of patients with non-ischemic cardiomyopathies.

    Keywords

    cardiac magentic resonance imaging, non-ischemic cardiomyopathy

    DOI

    https://doi.org/10.15836/ccar2018.401

    Literature

    1. Patel AR, Kramer CM. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2017 Oct;10 10 Pt A:1180–93. https://doi.org/10.1016/j.jcmg.2017.08.005
    2. Becker MAJ, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC Cardiovasc Imaging. 2018 Sep;11(9):1274–84. https://doi.org/10.1016/j.jcmg.2018.03.006
    Cardiologia Croatica
    Back to search

    Cardiac magnetic resonance in non-ischemic cardiomyopathies

    Extended Abstract
    Issue11-12
    Published
    Pages401
    PDF via DOIhttps://doi.org/10.15836/ccar2018.401
    cardiac magentic resonance imaging
    non-ischemic cardiomyopathy

    Authors

    Marko Boban*ORCIDKlinički bolnički centar Sestre milosrdnice, Zagreb, Hrvatska

    *Correspondence email: marcoboban@yahoo.com

    Abstract

    Cardiomyopathies are diseases of cardiomyocytes or different heart structures which are manifested through changes in morphology or function of the heart. Due to relatively non-negligible prevalence and clinical course, cardiomyopathies are significant public health burden in terms of increased utilization of medical services, impairing quality of life, as well as mortality. In the last decades, cardiac magnetic resonance (CMR) became important clinical tool in management of patients with non-ischemic cardiomyopathy (NICMP). CMR offers virtue of non-invasive 3D imaging of cardiac structures and function, and owing the advances in technology, there is a relatively constant pace of improvements in spatial, temporal resolutions, as well as tissue characterization. For these reasons use of CMR increases in every day clinical practice and growing number of centers is available. CMR brings diagnostic and prognostic advances in managed care of patients with cardiomyopathies, with ability to influence course of treatment and the most important increase survival of patients. Typical complications within the course of NICMP like development of heart failure, malignant arrhythmia and cardiac death could be verified, in part foreseen, and to different degree ameliorated by use of CMR. (1, 2) This lecture will present the most important issues around utilization of CMR in clinical management of patients with non-ischemic cardiomyopathies.

    Literature

    1. 1.
      Patel AR, Kramer CM. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2017 Oct;10 10 Pt A:1180–93.DOI
    2. 2.
      Becker MAJ, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC Cardiovasc Imaging. 2018 Sep;11(9):1274–84.DOI